<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00629902</url>
  </required_header>
  <id_info>
    <org_study_id>AT-1974</org_study_id>
    <nct_id>NCT00629902</nct_id>
  </id_info>
  <brief_title>Heart Valve Prosthesis-Patient Mismatch</brief_title>
  <official_title>Impact of Prosthesis-Patient Mismatch on Clinical Outcomes After Mitral Valve Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Florence Nightingale Hospital, Istanbul</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Florence Nightingale Hospital, Istanbul</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the frequency of prosthesis-patient mismatch after
      mitral valve replacement and its effect on clinical outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mitral valve replacement (MVR) is associated with higher short and long term mortality than
      aortic valve replacement or mitral valve repair. The suboptimal results of MVR underline the
      importance of identifying and preventing prosthesis- patient mismatch. The effective orifice
      area (EOA) of prosthetic valves used for MVR is often too small in relation to body size,
      thus causing a mismatch between valve EOA and transvalvular flow. As a consequence, normally
      functioning mitral prostheses often have relatively high gradients that are similar to those
      found in patients with mild to moderate mitral stenosis. Residual pressure gradients across
      mitral prostheses delay the regression of left atrial and pulmonary arterial hypertension.
      Pulmonary hypertension may cause rightsided failure and is an important risk factor for
      morbidity and mortality in patients with cardiovascular diseases. However data about the
      frequency of prosthesis-patient mismatch after mitral valve replacement and its effect on
      clinical outcome is inconclusive. Predetermined outcomes will be evaluated in the clinical
      course of this condition.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Heart Valve Diseases</condition>
  <arm_group>
    <arm_group_label>A1</arm_group_label>
    <description>Patients with prosthesis-patient mismatch after mitral valve replacement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A2</arm_group_label>
    <description>Patients without prosthesis mismatch after mitral valve replacement</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Tertiary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients &gt; 18 years with a clinical condition of mitral valve prosthesis

        Exclusion Criteria:

          -  Evidence of prosthesis valve dysfunction (dehisence, endocarditis or thrombus of
             prosthetic mitral valve)

          -  Concomitant aortic valve prosthesis and tricuspid valve prosthesis

          -  Presence of &gt; +2 aortic valve regurgitation and/or mild aortic stenosis

          -  Prosthetic mitral valve replacement operation &lt; 6 months

          -  Left ventricular ejection fraction &lt; 50%

          -  Chronic obstructive pulmonary disease

          -  Concomitant hypertrophic cardiomyopathy, atrial septal defect

          -  Patients with poor ehocardiographic window
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Saide Aytekin, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>T.C. Istanbul Bilim University, Medical Faculty, Florence Nightingale Hospital, Division of Cardiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>T.C. Bilim University, Medical Faculty, Florence Nightingale Hospital, Division of Cardiology</name>
      <address>
        <city>Istanbul</city>
        <state>Sisli</state>
        <zip>34381</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Totaro P, Argano V. Patient-prosthesis mismatch after mitral valve replacement: myth or reality? J Thorac Cardiovasc Surg. 2007 Sep;134(3):697-701.</citation>
    <PMID>17723820</PMID>
  </reference>
  <reference>
    <citation>Li M, Dumesnil JG, Mathieu P, Pibarot P. Impact of valve prosthesis-patient mismatch on pulmonary arterial pressure after mitral valve replacement. J Am Coll Cardiol. 2005 Apr 5;45(7):1034-40.</citation>
    <PMID>15808760</PMID>
  </reference>
  <reference>
    <citation>Magne J, Mathieu P, Dumesnil JG, Tann√© D, Dagenais F, Doyle D, Pibarot P. Impact of prosthesis-patient mismatch on survival after mitral valve replacement. Circulation. 2007 Mar 20;115(11):1417-25. Epub 2007 Mar 5.</citation>
    <PMID>17339554</PMID>
  </reference>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 27, 2008</study_first_submitted>
  <study_first_submitted_qc>March 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2008</study_first_posted>
  <last_update_submitted>May 9, 2008</last_update_submitted>
  <last_update_submitted_qc>May 9, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 12, 2008</last_update_posted>
  <responsible_party>
    <name_title>Saide Aytekin</name_title>
    <organization>Florence Nightingale Hospital</organization>
  </responsible_party>
  <keyword>Heart valve prosthesis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

